361 results in Exploration of Targeted Anti-tumor Therapy
Latest
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Review
Circulating tumor cells: overcoming challenges of detecting a needle in a haystack
Zhuldyz Myrkhiyeva ... Aliya Bekmurzayeva
Published: May 29, 2025 Explor Target Antitumor Ther. 2025;6:1002321
This article belongs to the special issue Liquid Biopsy: Has Already Changed the Clinical Decision-Making in Solid Tumors Treatment?
Open Access
Original Article
A viral circular RNA in Kaposi’s sarcoma-associated herpesvirus modulates viral and host gene expression during latent and lytic replication
Soleil Torres ... Rolf Renne
Published: May 29, 2025 Explor Target Antitumor Ther. 2025;6:1002320
This article belongs to the special issue Potential of Non-Coding RNAs in Cancer Research and Treatment
Open Access
Review
The DNA methylation landscape of musculoskeletal sarcomas
Mariana Chantre-Justino, Walter Meohas
Published: May 26, 2025 Explor Target Antitumor Ther. 2025;6:1002319
Open Access
Original Article
Prognostic impact of biomarkers in PMBCL: rationale for early integration of immune checkpoint inhibitors
Yana K. Mangasarova ... Andrey B. Sudarikov
Published: May 20, 2025 Explor Target Antitumor Ther. 2025;6:1002318
This article belongs to the special issue Immune Checkpoint Therapy and Biomarkers in Cancer
Open Access
Commentary
The role of circulating tumor DNA (ctDNA) in urothelial cancers
Jeanny B. Aragon-Ching
Published: May 19, 2025 Explor Target Antitumor Ther. 2025;6:1002317
This article belongs to the special issue Liquid Biopsy: Has Already Changed the Clinical Decision-Making in Solid Tumors Treatment?
Open Access
Systematic Review
Utility of CA-125 for diagnosis and prognosis of breast cancer: a systematic review
Zohre Momenimovahed ... Ibrahim Alkatout
Published: May 15, 2025 Explor Target Antitumor Ther. 2025;6:1002316
Open Access
Review
Harnessing the power of tumor-draining lymph nodes: unveiling predictive biomarkers for immune checkpoint inhibitor
Zihan Chen ... Lei Wang
Published: May 13, 2025 Explor Target Antitumor Ther. 2025;6:1002315
This article belongs to the special issue Novel Biomarkers in the Immunotherapy Era
Open Access
Review
The development and applications of circulating tumour cells, circulating tumour DNA and other emerging biomarkers for early cancer detection
David Sinclair Thomas Junior ... Yong-Jie Lu
Published: May 13, 2025 Explor Target Antitumor Ther. 2025;6:1002314
Open Access
Review
Neoantigen-based immunotherapy: advancing precision medicine in cancer and glioblastoma treatment through discovery and innovation
Moawiah M Naffaa ... Valiko Begiashvili
Published: April 27, 2025 Explor Target Antitumor Ther. 2025;6:1002313
Open Access
Review
Cytokine-based immunotherapy for gastric cancer: targeting inflammation for tumor control
Mathan Muthu Chinakannu Marimuthu ... Hitesh Chopra
Published: April 26, 2025 Explor Target Antitumor Ther. 2025;6:1002312
Open Access
Review
Viral infections and immune modulation in bladder cancer: implications for immunotherapy
Lívia Bitencourt Pascoal ... Leonardo O. Reis
Published: April 24, 2025 Explor Target Antitumor Ther. 2025;6:1002311
This article belongs to the special issue Comprehensive Immunotherapy of Solid Tumors
Open Access
Review
Modulation of anti-tumour immunity by XPO1 inhibitors
Jack G. Fisher ... Matthew D. Blunt
Published: April 23, 2025 Explor Target Antitumor Ther. 2025;6:1002310
This article belongs to the special issue Immune Checkpoint Therapy and Biomarkers in Cancer
Open Access
Case Report
Eosinophil cytolysis with or without ETosis in four cases of human gastric cancer: a comparative ultrastructural study
Rosario Caruso ... Luciana Rigoli
Published: April 21, 2025 Explor Target Antitumor Ther. 2025;6:1002309
Open Access
Review
Nanoimmunotherapy: the smart trooper for cancer therapy
Suphiya Parveen ... Fahima Dilnawaz
Published: April 10, 2025 Explor Target Antitumor Ther. 2025;6:1002308
This article belongs to the special issue Comprehensive Immunotherapy of Solid Tumors
Open Access
Review
Strategies to overcome resistance to enfortumab vedotin and pembrolizumab for patients with urothelial carcinoma: harnessing present knowledge for future advances
Albert Jang, Jason R. Brown
Published: April 07, 2025 Explor Target Antitumor Ther. 2025;6:1002307
This article belongs to the special issue Emerging Molecular Targets and Therapies of Genitourinary Tumors
Open Access
Review
Exploring recent advances in signaling pathways and hallmarks of uveal melanoma: a comprehensive review
Majid Banimohammad ... Hamidreza Pazoki-Toroudi
Published: April 02, 2025 Explor Target Antitumor Ther. 2025;6:1002306
This article belongs to the special issue Predictive and Prognostic Biomarkers in Cancer: Towards the Precision Medicine Era
Open Access
Short Communication
Real-world outcomes of lenvatinib plus pembrolizumab in intermediate- and poor-risk metastatic renal cell carcinoma
Ilya Tsimafeyeu ... Mark Gluzman
Published: April 01, 2025 Explor Target Antitumor Ther. 2025;6:1002305
This article belongs to the special issue Emerging Molecular Targets and Therapies of Genitourinary Tumors
Open Access
Review
Key immune cells and their crosstalk in the tumor microenvironment of bladder cancer: insights for innovative therapies
Anna Di Spirito ... Lorenzo Mortara
Published: March 31, 2025 Explor Target Antitumor Ther. 2025;6:1002304
This article belongs to the special issue Novel Insights into Immunotherapy Targeting Tumor Microenvironment in Cancer
Open Access
Review
State-of-the-art photodynamic therapy for malignant gliomas: innovations in photosensitizers and combined therapeutic approaches
Bruno A. Cesca ... Luis E. Ibarra
Published: March 28, 2025 Explor Target Antitumor Ther. 2025;6:1002303
Open Access
Review
Advances in adoptive cell therapies in small cell lung cancer
Eljie Isaak Bragasin ... Robert Hsu
Published: March 26, 2025 Explor Target Antitumor Ther. 2025;6:1002302
This article belongs to the special issue Comprehensive Immunotherapy of Solid Tumors
Previous